RemAb Therapeutics' Incubator/Accelerator Round

RemAb Therapeutics raised a round of funding on August 09, 2018. Investors include European Institute of Innovation and Technology.

RemAb is developing an advanced medical solution to prevent nosocomial infections by Gram-negative bacteria. The treatment is based on the systemic elimination of inhibitory natural anti-glycan antibo…

Articles about RemAb Therapeutics' Incubator/Accelerator Round: